THAILANSTATINANALOGA

Patent europeic · EP3684773 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3684773
Numer da la dumonda
EP18789726
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-09-2018
Publitgà
29-07-2020
Concedì
29-04-2026
La protecziun finescha il pli tard
18-09-2038
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
C07D 493/04 (2006.01)
A61P 35/00 (2006.01)
A61K 31/352 (2006.01)
Prioritad
US 201762561060 P 20.09.2017
US 201862686781 P 19.06.2018
Dumonda PCT
PCT/US2018/051721 19.09.2018
Publicaziun PCT
WO2019/060398 28.03.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 29-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.04.2026

Partidas

Possessur

pH Pharma Co., Ltd.

9F, The-K Twin Towers A 50 Jongno 1-Gil Jongno-Gu, Seoul 03142, KR

Inventur

JAMMALAMADAKA, Vasu

Dublin, California 94568, US

TIPTON, Kimberly Ann

San Francisco, California 94122, US

SATYAL, Sanjeev

San Carlos, California 94070, US

HUH, Hoyoung

Portola Valley, California 94028, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.